ask="20.95"
ask_size="100"
average_daily_volume="190280"
bid="12.15"
bid_size="100"
book_value="7.04"
change="-0.25"
change_from_200_day_moving_average="5.27"
change_from_50_day_moving_average="2.30"
change_from_52_week_high="-13.85"
change_From_52_week_low="8.35"
change_in_percent="-1.19%"
close="20.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-79.91M"
eps_estimate_current_year="-3.22"
eps_estimate_next_quarter="-0.97"
eps_estimate_next_year="-3.30"
ex_dividend_date="N/A"
float_shares="18659000"
high="21.15"
high_52_weeks="34.55"
last_trade_date="12/30/2016"
last_trade_price="20.70"
last_trade_size="9062"
last_trade_time="4:00pm"
low="20.45"
low_52_weeks="12.35"
market_capitalization="590.26M"
moving_average_200_day="15.43"
moving_average_50_day="18.40"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="34.60"
open="20.95"
pe_ratio="N/A"
peg_ratio="-0.56"
percent_change_from_200_day_moving_average="+34.14%"
percent_change_from_50_day_moving_average="+12.52%"
percent_change_from_52_week_high="-40.09%"
percent_change_from_52_week_low="+67.61%"
previous_close="20.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.98"
price_per_sales="1991.30"
revenue="300000.00"
shares_outstanding="28515000"
short_ratio="27.10"
stock_exchange="NGM"
symbol="RVNC"
volume="72030"
weeks_range_52="12.35 - 34.55"
